| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Moshe Rogosnitzky | Q94567752 |
| P2093 | author name string | April Ingram | |
| Itzhak Isakov | |||
| Wjatschesslaw Wlassoff | |||
| Y Robert Barishak | |||
| P2860 | cites work | [Use of disaggregants in treating diabetic retinopathy] | Q70759170 |
| Effect of dipyridamole on vascular responses of porcine ciliary arteries | Q71161010 | ||
| [Tonographic changes caused by dipyridamol] | Q71332953 | ||
| The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus | Q71798791 | ||
| Short-term effect of dipyridamole on blood flow velocities in the extraocular vessels | Q71908586 | ||
| The pyrimido-pyrimidine derivatives, dipyridamole and RA-642, reduce opacification of crystalline lens in diabetic rats | Q72579229 | ||
| Experimental retinopathy of prematurity: angiostatic inhibition by nimodipine, ginkgo-biloba, and dipyridamole, and response to different growth factors | Q73614533 | ||
| Effect of a cGMP-specific phosphodiesterase inhibitor on retinal function | Q77144696 | ||
| Antiplatelet agents for stroke prevention | Q84563055 | ||
| Adenosine and its agonists cause retinal vasodilation and hemorrhages. Implications for ischemic retinopathies | Q30458375 | ||
| The potential role of adenosine in regulating blood flow in the eye. | Q36436366 | ||
| Translational therapeutics of dipyridamole | Q37041703 | ||
| Dipyridamole, cerebrovascular disease, and the vasculature | Q37110642 | ||
| Phosphodiesterase inhibitors and the eye. | Q37558566 | ||
| Pterygium: nonsurgical treatment using topical dipyridamole - a case report | Q37716197 | ||
| Effect of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia. | Q37800993 | ||
| alpha2 But not alpha1 AMP-activated protein kinase mediates oxidative stress-induced inhibition of retinal pigment epithelium cell phagocytosis of photoreceptor outer segments. | Q40025193 | ||
| Modulation of neurotransmission by purine nucleotides and nucleosides | Q40121594 | ||
| Effect of dipyridamole on prostaglandin-induced ocular hypertension in rabbits | Q41627928 | ||
| The effect of dipyridamole on vascular cell-derived reactive oxygen species | Q42481785 | ||
| Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study | Q42629542 | ||
| Dipyridamole and RA-642 inhibit the production of superoxide anion and free radical damage to rat lens | Q43520874 | ||
| Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis. | Q45969556 | ||
| Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection | Q46054691 | ||
| The use of dipyridamole (curantyl) in combination with alpha-lipoic acid in the treatment of diabetic neuropathy with retinopathy | Q46333621 | ||
| Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group | Q69489643 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | route of administration | Q621636 |
| eye disease | Q3041498 | ||
| vasodilator agent | Q4008956 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 83-89 | |
| P577 | publication date | 2015-12-22 | |
| 2016-03-01 | |||
| P1433 | published in | Journal of Ocular Pharmacology and Therapeutics | Q15755845 |
| P1476 | title | Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration | |
| P478 | volume | 32 |
Search more.